Bendamax
Bendamax is Bendamustine, an alkylating antineoplastic agent. It is indicated for chronic lymphocytic leukemia and indolent non-Hodgkin lymphoma and works by causing DNA cross-linking and cancer cell death.
Features
| Product Name | Bendamax |
| Generic Name | Bendamustine |
| Formulation | Injectable |
| Available Pack Size | 1X1's |
| Available Strength | 25 MG |